1. Home
  2. AXTI vs CLYM Comparison

AXTI vs CLYM Comparison

Compare AXTI & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • CLYM
  • Stock Information
  • Founded
  • AXTI 1986
  • CLYM 2018
  • Country
  • AXTI United States
  • CLYM United States
  • Employees
  • AXTI N/A
  • CLYM N/A
  • Industry
  • AXTI Semiconductors
  • CLYM
  • Sector
  • AXTI Technology
  • CLYM
  • Exchange
  • AXTI Nasdaq
  • CLYM NYSE
  • Market Cap
  • AXTI 84.8M
  • CLYM 83.8M
  • IPO Year
  • AXTI 1998
  • CLYM 2021
  • Fundamental
  • Price
  • AXTI $2.56
  • CLYM $1.36
  • Analyst Decision
  • AXTI Strong Buy
  • CLYM Buy
  • Analyst Count
  • AXTI 4
  • CLYM 1
  • Target Price
  • AXTI $4.69
  • CLYM $10.00
  • AVG Volume (30 Days)
  • AXTI 728.8K
  • CLYM 389.7K
  • Earning Date
  • AXTI 07-31-2025
  • CLYM 08-13-2025
  • Dividend Yield
  • AXTI N/A
  • CLYM N/A
  • EPS Growth
  • AXTI N/A
  • CLYM N/A
  • EPS
  • AXTI N/A
  • CLYM N/A
  • Revenue
  • AXTI $96,029,000.00
  • CLYM N/A
  • Revenue This Year
  • AXTI N/A
  • CLYM N/A
  • Revenue Next Year
  • AXTI $27.18
  • CLYM N/A
  • P/E Ratio
  • AXTI N/A
  • CLYM N/A
  • Revenue Growth
  • AXTI 21.44
  • CLYM N/A
  • 52 Week Low
  • AXTI $1.13
  • CLYM $1.05
  • 52 Week High
  • AXTI $4.03
  • CLYM $9.21
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 69.02
  • CLYM N/A
  • Support Level
  • AXTI $1.97
  • CLYM N/A
  • Resistance Level
  • AXTI $2.49
  • CLYM N/A
  • Average True Range (ATR)
  • AXTI 0.15
  • CLYM 0.00
  • MACD
  • AXTI 0.02
  • CLYM 0.00
  • Stochastic Oscillator
  • AXTI 89.13
  • CLYM 0.00

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Share on Social Networks: